Clinical Trial Update: Interleukin- 17 (IL-17), Bcl-3, and NF-kappa-B Inhibitor Zeta (IκBζ) Expression Levels in the Psoriasis Patients

View source ↗

Summary

This clinical trial update reports on expression levels of IL-17, Bcl-3, and IκBζ in psoriasis patients to study inflammatory pathway activity. Periodontal dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontal Diseases
• Psoriasis

Snippet

Sponsor: Kahramanmaras Sutcu Imam University | Conditions: Psoriasis, Periodontal Diseases | Status: COMPLETED